173 related articles for article (PubMed ID: 34556859)
1. ATP-competitive partial antagonists of the IRE1α RNase segregate outputs of the UPR.
Feldman HC; Ghosh R; Auyeung VC; Mueller JL; Kim JH; Potter ZE; Vidadala VN; Perera BGK; Olivier A; Backes BJ; Zikherman J; Papa FR; Maly DJ
Nat Chem Biol; 2021 Nov; 17(11):1148-1156. PubMed ID: 34556859
[TBL] [Abstract][Full Text] [Related]
2. Structural and Functional Analysis of the Allosteric Inhibition of IRE1α with ATP-Competitive Ligands.
Feldman HC; Tong M; Wang L; Meza-Acevedo R; Gobillot TA; Lebedev I; Gliedt MJ; Hari SB; Mitra AK; Backes BJ; Papa FR; Seeliger MA; Maly DJ
ACS Chem Biol; 2016 Aug; 11(8):2195-205. PubMed ID: 27227314
[TBL] [Abstract][Full Text] [Related]
3. Allosteric inhibition of the IRE1α RNase preserves cell viability and function during endoplasmic reticulum stress.
Ghosh R; Wang L; Wang ES; Perera BG; Igbaria A; Morita S; Prado K; Thamsen M; Caswell D; Macias H; Weiberth KF; Gliedt MJ; Alavi MV; Hari SB; Mitra AK; Bhhatarai B; Schürer SC; Snapp EL; Gould DB; German MS; Backes BJ; Maly DJ; Oakes SA; Papa FR
Cell; 2014 Jul; 158(3):534-48. PubMed ID: 25018104
[TBL] [Abstract][Full Text] [Related]
4. IRE1alpha kinase activation modes control alternate endoribonuclease outputs to determine divergent cell fates.
Han D; Lerner AG; Vande Walle L; Upton JP; Xu W; Hagen A; Backes BJ; Oakes SA; Papa FR
Cell; 2009 Aug; 138(3):562-75. PubMed ID: 19665977
[TBL] [Abstract][Full Text] [Related]
5. Long-Range Inhibitor-Induced Conformational Regulation of Human IRE1α Endoribonuclease Activity.
Concha NO; Smallwood A; Bonnette W; Totoritis R; Zhang G; Federowicz K; Yang J; Qi H; Chen S; Campobasso N; Choudhry AE; Shuster LE; Evans KA; Ralph J; Sweitzer S; Heerding DA; Buser CA; Su DS; DeYoung MP
Mol Pharmacol; 2015 Dec; 88(6):1011-23. PubMed ID: 26438213
[TBL] [Abstract][Full Text] [Related]
6. Identification of autophosphorylation inhibitors of the inositol-requiring enzyme 1 alpha (IRE1α) by high-throughput screening using a DELFIA assay.
Newbatt Y; Hardcastle A; McAndrew PC; Strover JA; Mirza A; Morgan GJ; Burke R; Davies FE; Collins I; van Montfort RL
J Biomol Screen; 2013 Mar; 18(3):298-308. PubMed ID: 23139381
[TBL] [Abstract][Full Text] [Related]
7. Divergent allosteric control of the IRE1α endoribonuclease using kinase inhibitors.
Wang L; Perera BG; Hari SB; Bhhatarai B; Backes BJ; Seeliger MA; Schürer SC; Oakes SA; Papa FR; Maly DJ
Nat Chem Biol; 2012 Dec; 8(12):982-9. PubMed ID: 23086298
[TBL] [Abstract][Full Text] [Related]
8. Small molecule inhibition of IRE1α kinase/RNase has anti-fibrotic effects in the lung.
Thamsen M; Ghosh R; Auyeung VC; Brumwell A; Chapman HA; Backes BJ; Perara G; Maly DJ; Sheppard D; Papa FR
PLoS One; 2019; 14(1):e0209824. PubMed ID: 30625178
[TBL] [Abstract][Full Text] [Related]
9. The endoplasmic reticulum stress sensor IRE1α protects cells from apoptosis induced by the coronavirus infectious bronchitis virus.
Fung TS; Liao Y; Liu DX
J Virol; 2014 Nov; 88(21):12752-64. PubMed ID: 25142592
[TBL] [Abstract][Full Text] [Related]
10. ER stress and distinct outputs of the IRE1α RNase control proliferation and senescence in response to oncogenic Ras.
Blazanin N; Son J; Craig-Lucas AB; John CL; Breech KJ; Podolsky MA; Glick AB
Proc Natl Acad Sci U S A; 2017 Sep; 114(37):9900-9905. PubMed ID: 28847931
[TBL] [Abstract][Full Text] [Related]
11. Profiling the Dual Enzymatic Activities of the Serine/Threonine Kinase IRE1α.
Feldman HC; Maly DJ
Methods Mol Biol; 2017; 1513():233-242. PubMed ID: 27807842
[TBL] [Abstract][Full Text] [Related]
12. Opposite Roles of RNase and Kinase Activities of Inositol-Requiring Enzyme 1 (IRE1) on HSV-1 Replication.
Su A; Wang H; Li Y; Wang X; Chen D; Wu Z
Viruses; 2017 Aug; 9(9):. PubMed ID: 28832521
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Diverges from Other Betacoronaviruses in Only Partially Activating the IRE1α/XBP1 Endoplasmic Reticulum Stress Pathway in Human Lung-Derived Cells.
Nguyen LC; Renner DM; Silva D; Yang D; Parenti NA; Medina KM; Nicolaescu V; Gula H; Drayman N; Valdespino A; Mohamed A; Dann C; Wannemo K; Robinson-Mailman L; Gonzalez A; Stock L; Cao M; Qiao Z; Moellering RE; Tay S; Randall G; Beers MF; Rosner MR; Oakes SA; Weiss SR
mBio; 2022 Oct; 13(5):e0241522. PubMed ID: 36125275
[TBL] [Abstract][Full Text] [Related]
14. A kinase inhibitor activates the IRE1alpha RNase to confer cytoprotection against ER stress.
Han D; Upton JP; Hagen A; Callahan J; Oakes SA; Papa FR
Biochem Biophys Res Commun; 2008 Jan; 365(4):777-83. PubMed ID: 18035051
[TBL] [Abstract][Full Text] [Related]
15. HSP72 protects cells from ER stress-induced apoptosis via enhancement of IRE1alpha-XBP1 signaling through a physical interaction.
Gupta S; Deepti A; Deegan S; Lisbona F; Hetz C; Samali A
PLoS Biol; 2010 Jul; 8(7):e1000410. PubMed ID: 20625543
[TBL] [Abstract][Full Text] [Related]
16. A Human IRE1 Inhibitor Blocks the Unfolded Protein Response in the Pathogenic Fungus Aspergillus fumigatus and Suggests Noncanonical Functions within the Pathway.
Guirao-Abad JP; Weichert M; Albee A; Deck K; Askew DS
mSphere; 2020 Oct; 5(5):. PubMed ID: 33087521
[TBL] [Abstract][Full Text] [Related]
17. The unfolded protein response sensor IRE1alpha is required at 2 distinct steps in B cell lymphopoiesis.
Zhang K; Wong HN; Song B; Miller CN; Scheuner D; Kaufman RJ
J Clin Invest; 2005 Feb; 115(2):268-81. PubMed ID: 15690081
[TBL] [Abstract][Full Text] [Related]
18. Triazoloacridone C-1305 impairs XBP1 splicing by acting as a potential IRE1α endoribonuclease inhibitor.
Bartoszewska S; Króliczewski J; Crossman DK; Pogorzelska A; Bagiński M; Collawn JF; Bartoszewski R
Cell Mol Biol Lett; 2021 Mar; 26(1):11. PubMed ID: 33730996
[TBL] [Abstract][Full Text] [Related]
19. Parallel Signaling through IRE1α and PERK Regulates Pancreatic Neuroendocrine Tumor Growth and Survival.
Moore PC; Qi JY; Thamsen M; Ghosh R; Peng J; Gliedt MJ; Meza-Acevedo R; Warren RE; Hiniker A; Kim GE; Maly DJ; Backes BJ; Papa FR; Oakes SA
Cancer Res; 2019 Dec; 79(24):6190-6203. PubMed ID: 31672843
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of IRE1α-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia.
Sun H; Lin DC; Guo X; Kharabi Masouleh B; Gery S; Cao Q; Alkan S; Ikezoe T; Akiba C; Paquette R; Chien W; Müller-Tidow C; Jing Y; Agelopoulos K; Müschen M; Koeffler HP
Oncotarget; 2016 Apr; 7(14):18736-49. PubMed ID: 26934650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
